Form 8-K - Current report:
SEC Accession No. 0001104659-26-071358
Filing Date
2026-06-08
Accepted
2026-06-08 16:00:57
Documents
13
Period of Report
2026-06-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2615356d2_8k.htm   iXBRL 8-K 44947
2 EXHIBIT 10.1 tm2615356d2_ex10-1.htm EX-10.1 5086
6 GRAPHIC tm2615356d2_8kimg001.jpg GRAPHIC 16480
  Complete submission text file 0001104659-26-071358.txt   265609

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mtva-20260608.xsd EX-101.SCH 3017
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mtva-20260608_lab.xml EX-101.LAB 34239
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mtva-20260608_pre.xml EX-101.PRE 22360
16 EXTRACTED XBRL INSTANCE DOCUMENT tm2615356d2_8k_htm.xml XML 3209
Mailing Address 545 CONCORD AVENUE SUITE 210 CAMBRIDGE MA 02138
Business Address 545 CONCORD AVENUE SUITE 210 CAMBRIDGE MA 02138 (857) 702-9600
MetaVia Inc. (Filer) CIK: 0001638287 (see all company filings)

EIN.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37809 | Film No.: 261072494
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)